OPERA LTD-ADR (OPRA) Fundamental Analysis & Valuation

NASDAQ:OPRAUS68373M1071

Current stock price

13.72 USD
-0.27 (-1.93%)
At close:
13.72 USD
0 (0%)
After Hours:

This OPRA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. OPRA Profitability Analysis

1.1 Basic Checks

  • OPRA had positive earnings in the past year.
  • In the past year OPRA had a positive cash flow from operations.
  • OPRA had positive earnings in 4 of the past 5 years.
  • In the past 5 years OPRA always reported a positive cash flow from operatings.
OPRA Yearly Net Income VS EBIT VS OCF VS FCFOPRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

1.2 Ratios

  • OPRA has a better Return On Assets (9.47%) than 85.97% of its industry peers.
  • OPRA has a better Return On Equity (10.71%) than 76.26% of its industry peers.
  • OPRA has a Return On Invested Capital of 7.57%. This is in the better half of the industry: OPRA outperforms 79.14% of its industry peers.
  • OPRA had an Average Return On Invested Capital over the past 3 years of 7.18%. This is below the industry average of 10.92%.
  • The last Return On Invested Capital (7.57%) for OPRA is above the 3 year average (7.18%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.47%
ROE 10.71%
ROIC 7.57%
ROA(3y)10.76%
ROA(5y)5.96%
ROE(3y)11.99%
ROE(5y)6.66%
ROIC(3y)7.18%
ROIC(5y)N/A
OPRA Yearly ROA, ROE, ROICOPRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5 10 15

1.3 Margins

  • The Profit Margin of OPRA (17.62%) is better than 83.81% of its industry peers.
  • In the last couple of years the Profit Margin of OPRA has declined.
  • The Operating Margin of OPRA (14.98%) is better than 82.37% of its industry peers.
  • OPRA's Operating Margin has improved in the last couple of years.
  • OPRA has a Gross Margin of 64.11%. This is comparable to the rest of the industry: OPRA outperforms 42.81% of its industry peers.
  • OPRA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.98%
PM (TTM) 17.62%
GM 64.11%
OM growth 3Y3.33%
OM growth 5Y77.52%
PM growth 3Y57.33%
PM growth 5Y-29.54%
GM growth 3Y-8.44%
GM growth 5Y-7.62%
OPRA Yearly Profit, Operating, Gross MarginsOPRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80 100

8

2. OPRA Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), OPRA is destroying value.
  • Compared to 1 year ago, OPRA has more shares outstanding
  • Compared to 5 years ago, OPRA has less shares outstanding
  • The debt/assets ratio for OPRA has been reduced compared to a year ago.
OPRA Yearly Shares OutstandingOPRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
OPRA Yearly Total Debt VS Total AssetsOPRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

2.2 Solvency

  • OPRA has an Altman-Z score of 7.48. This indicates that OPRA is financially healthy and has little risk of bankruptcy at the moment.
  • OPRA has a better Altman-Z score (7.48) than 86.69% of its industry peers.
  • The Debt to FCF ratio of OPRA is 0.07, which is an excellent value as it means it would take OPRA, only 0.07 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 0.07, OPRA belongs to the top of the industry, outperforming 81.30% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that OPRA is not too dependend on debt financing.
  • The Debt to Equity ratio of OPRA (0.00) is better than 65.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Altman-Z 7.48
ROIC/WACC0.89
WACC8.55%
OPRA Yearly LT Debt VS Equity VS FCFOPRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

2.3 Liquidity

  • OPRA has a Current Ratio of 2.35. This indicates that OPRA is financially healthy and has no problem in meeting its short term obligations.
  • OPRA has a Current ratio of 2.35. This is in the better half of the industry: OPRA outperforms 65.47% of its industry peers.
  • OPRA has a Quick Ratio of 2.35. This indicates that OPRA is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of OPRA (2.35) is better than 66.19% of its industry peers.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 2.35
OPRA Yearly Current Assets VS Current LiabilitesOPRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

8

3. OPRA Growth Analysis

3.1 Past

  • OPRA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.49%, which is quite good.
  • OPRA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 22.48% yearly.
  • OPRA shows a strong growth in Revenue. In the last year, the Revenue has grown by 27.21%.
  • Measured over the past years, OPRA shows a very strong growth in Revenue. The Revenue has been growing by 28.32% on average per year.
EPS 1Y (TTM)16.49%
EPS 3Y67.61%
EPS 5Y22.48%
EPS Q2Q%7.14%
Revenue 1Y (TTM)27.21%
Revenue growth 3Y22.84%
Revenue growth 5Y28.32%
Sales Q2Q%21.52%

3.2 Future

  • The Earnings Per Share is expected to grow by 20.46% on average over the next years. This is a very strong growth
  • OPRA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.86% yearly.
EPS Next Y30.11%
EPS Next 2Y22.83%
EPS Next 3Y19.8%
EPS Next 5Y20.46%
Revenue Next Year21.42%
Revenue Next 2Y18.34%
Revenue Next 3Y15.9%
Revenue Next 5Y14.86%

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
OPRA Yearly Revenue VS EstimatesOPRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
OPRA Yearly EPS VS EstimatesOPRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1 2 3

8

4. OPRA Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 12.14, OPRA is valued correctly.
  • 84.89% of the companies in the same industry are more expensive than OPRA, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 25.61. OPRA is valued rather cheaply when compared to this.
  • A Price/Forward Earnings ratio of 9.33 indicates a reasonable valuation of OPRA.
  • 84.89% of the companies in the same industry are more expensive than OPRA, based on the Price/Forward Earnings ratio.
  • OPRA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.79.
Industry RankSector Rank
PE 12.14
Fwd PE 9.33
OPRA Price Earnings VS Forward Price EarningsOPRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • OPRA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. OPRA is cheaper than 87.77% of the companies in the same industry.
  • 87.05% of the companies in the same industry are more expensive than OPRA, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 10.96
EV/EBITDA 9.98
OPRA Per share dataOPRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

  • OPRA's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • The decent profitability rating of OPRA may justify a higher PE ratio.
  • OPRA's earnings are expected to grow with 19.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.4
PEG (5Y)0.54
EPS Next 2Y22.83%
EPS Next 3Y19.8%

5

5. OPRA Dividend Analysis

5.1 Amount

  • OPRA has a Yearly Dividend Yield of 5.21%, which is a nice return.
  • OPRA's Dividend Yield is rather good when compared to the industry average which is at 0.64. OPRA pays more dividend than 97.12% of the companies in the same industry.
  • OPRA's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 5.21%

5.2 History

  • OPRA has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
OPRA Yearly Dividends per shareOPRA Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.2 0.4 0.6 0.8 1

5.3 Sustainability

  • OPRA pays out 65.72% of its income as dividend. This is not a sustainable payout ratio.
DP65.72%
EPS Next 2Y22.83%
EPS Next 3Y19.8%
OPRA Yearly Income VS Free CF VS DividendOPRA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M
OPRA Dividend Payout.OPRA Dividend Payout, showing the Payout Ratio.OPRA Dividend Payout.PayoutRetained Earnings

OPRA Fundamentals: All Metrics, Ratios and Statistics

OPERA LTD-ADR

NASDAQ:OPRA (3/25/2026, 8:00:02 PM)

After market: 13.72 0 (0%)

13.72

-0.27 (-1.93%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-26
Earnings (Next)04-27
Inst Owners19.15%
Inst Owner Change3.15%
Ins OwnersN/A
Ins Owner Change0%
Market Cap1.23B
Revenue(TTM)614.45M
Net Income(TTM)108.28M
Analysts83.08
Price Target25.57 (86.37%)
Short Float %7.18%
Short Ratio3.94
Dividend
Industry RankSector Rank
Dividend Yield 5.21%
Yearly Dividend0.8
Dividend Growth(5Y)N/A
DP65.72%
Div Incr Years0
Div Non Decr Years0
Ex-Date01-07
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.94%
Min EPS beat(2)-22.87%
Max EPS beat(2)-11.01%
EPS beat(4)1
Avg EPS beat(4)-6.76%
Min EPS beat(4)-22.87%
Max EPS beat(4)8.78%
EPS beat(8)3
Avg EPS beat(8)-6.02%
EPS beat(12)6
Avg EPS beat(12)40.8%
EPS beat(16)7
Avg EPS beat(16)-5.98%
Revenue beat(2)2
Avg Revenue beat(2)2.93%
Min Revenue beat(2)0.56%
Max Revenue beat(2)5.29%
Revenue beat(4)4
Avg Revenue beat(4)3.36%
Min Revenue beat(4)0.56%
Max Revenue beat(4)6.51%
Revenue beat(8)6
Avg Revenue beat(8)2.04%
Revenue beat(12)9
Avg Revenue beat(12)1.47%
Revenue beat(16)13
Avg Revenue beat(16)2.24%
PT rev (1m)0%
PT rev (3m)-1.68%
EPS NQ rev (1m)-15.08%
EPS NQ rev (3m)-9.66%
EPS NY rev (1m)-9.6%
EPS NY rev (3m)-2.05%
Revenue NQ rev (1m)7.2%
Revenue NQ rev (3m)7.01%
Revenue NY rev (1m)5.92%
Revenue NY rev (3m)5.63%
Valuation
Industry RankSector Rank
PE 12.14
Fwd PE 9.33
P/S 2
P/FCF 10.96
P/OCF 10.45
P/B 1.22
P/tB 2.55
EV/EBITDA 9.98
EPS(TTM)1.13
EY8.24%
EPS(NY)1.47
Fwd EY10.72%
FCF(TTM)1.25
FCFY9.12%
OCF(TTM)1.31
OCFY9.57%
SpS6.85
BVpS11.27
TBVpS5.37
PEG (NY)0.4
PEG (5Y)0.54
Graham Number16.93
Profitability
Industry RankSector Rank
ROA 9.47%
ROE 10.71%
ROCE 8.98%
ROIC 7.57%
ROICexc 8.92%
ROICexgc 22.82%
OM 14.98%
PM (TTM) 17.62%
GM 64.11%
FCFM 18.26%
ROA(3y)10.76%
ROA(5y)5.96%
ROE(3y)11.99%
ROE(5y)6.66%
ROIC(3y)7.18%
ROIC(5y)N/A
ROICexc(3y)8.27%
ROICexc(5y)N/A
ROICexgc(3y)22.13%
ROICexgc(5y)N/A
ROCE(3y)8.52%
ROCE(5y)N/A
ROICexgc growth 3Y14.94%
ROICexgc growth 5Y134.47%
ROICexc growth 3Y22.52%
ROICexc growth 5Y130.89%
OM growth 3Y3.33%
OM growth 5Y77.52%
PM growth 3Y57.33%
PM growth 5Y-29.54%
GM growth 3Y-8.44%
GM growth 5Y-7.62%
F-Score7
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.07
Debt/EBITDA 0.04
Cap/Depr 29.4%
Cap/Sales 0.9%
Interest Coverage 150.85
Cash Conversion 106.18%
Profit Quality 103.6%
Current Ratio 2.35
Quick Ratio 2.35
Altman-Z 7.48
F-Score7
WACC8.55%
ROIC/WACC0.89
Cap/Depr(3y)65.11%
Cap/Depr(5y)44.73%
Cap/Sales(3y)2.09%
Cap/Sales(5y)1.53%
Profit Quality(3y)85.76%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.49%
EPS 3Y67.61%
EPS 5Y22.48%
EPS Q2Q%7.14%
EPS Next Y30.11%
EPS Next 2Y22.83%
EPS Next 3Y19.8%
EPS Next 5Y20.46%
Revenue 1Y (TTM)27.21%
Revenue growth 3Y22.84%
Revenue growth 5Y28.32%
Sales Q2Q%21.52%
Revenue Next Year21.42%
Revenue Next 2Y18.34%
Revenue Next 3Y15.9%
Revenue Next 5Y14.86%
EBIT growth 1Y-0.39%
EBIT growth 3Y26.93%
EBIT growth 5Y127.8%
EBIT Next Year88.94%
EBIT Next 3Y36.85%
EBIT Next 5Y28.05%
FCF growth 1Y37.42%
FCF growth 3Y28.02%
FCF growth 5Y4.84%
OCF growth 1Y12.15%
OCF growth 3Y27.61%
OCF growth 5Y4.76%

OPERA LTD-ADR / OPRA Fundamental Analysis FAQ

What is the ChartMill fundamental rating of OPERA LTD-ADR (OPRA) stock?

ChartMill assigns a fundamental rating of 8 / 10 to OPRA.


What is the valuation status of OPERA LTD-ADR (OPRA) stock?

ChartMill assigns a valuation rating of 8 / 10 to OPERA LTD-ADR (OPRA). This can be considered as Undervalued.


Can you provide the profitability details for OPERA LTD-ADR?

OPERA LTD-ADR (OPRA) has a profitability rating of 7 / 10.


How financially healthy is OPERA LTD-ADR?

The financial health rating of OPERA LTD-ADR (OPRA) is 8 / 10.


What is the earnings growth outlook for OPERA LTD-ADR?

The Earnings per Share (EPS) of OPERA LTD-ADR (OPRA) is expected to grow by 30.11% in the next year.